Andrew Obenshain
Chief Executive Officer chez BLUEBIRD BIO, INC.
Fortune : 358 397 $ au 31/03/2024
Profil
Andrew Obenshain is currently the President, Chief Executive Officer & Director at bluebird bio, Inc. since 2021.
He is also currently serving as a Director at bluebird bio (UK) Ltd.
since 2017.
Previously, he worked as the General Manager-Finance at Shire France SAS.
Mr. Obenshain completed his undergraduate degree at Dartmouth College and holds an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0,15% | 04/03/2024 | 279 998 ( 0,15% ) | 358 397 $ | 31/03/2024 |
Postes actifs de Andrew Obenshain
| Sociétés | Poste | Début |
|---|---|---|
| BLUEBIRD BIO, INC. | Chief Executive Officer | 04/11/2021 |
bluebird bio (UK) Ltd.
 bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Director/Board Member | 30/03/2017 |
Anciens postes connus de Andrew Obenshain
| Sociétés | Poste | Fin |
|---|---|---|
Shire France SAS
 Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Formation de Andrew Obenshain
| Dartmouth College | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Health Technology |
